Antimicrobial drug resistance is one of the major threats to global health. It has made
common infections increasingly difficult or impossible to treat, and leads to higher medical …

Covering: 2000 to 2018, particularly from 2010 to early 2018 The increase in the incidence
of antibiotic resistant infections is threatening to overwhelm healthcare practices worldwide …

Background Enterococcal bacteraemia (EB) is common, particularly in the nosocomial
setting, and its management poses a challenge for clinicians and microbiologists. Objectives …

Background and Aim: The predominant species of the Enterococcus, Enterococcus faecalis
(E. faecalis) and Enterococcus faecium (E. faecium) cause great variety of infections …

The 29th edition of Clinical and Laboratory Standards Institute (CLSI) document M100,
Performance Standards for Antimicrobial Susceptibility Testing, was published in January …

Introduction: The role of enterococci in infectious diseases has evolved from a gut and
urinary commensal to a major pathogen of concern. Few options exist for resistant …

Infective endocarditis, osteomyelitis, and osteosynthesis-associated infections are mostly
caused by Gram-positive bacteria. They are often difficult to treat and are associated with a …

Multidrug-resistant (MDR) Enterococcus faecium is a challenging nosocomial pathogen
known to colonize medical device surfaces and form biofilms. Bacterio (phages) may …

Daptomycin is one of the few treatment options for infections caused by enterococci that are
resistant to ampicillin and vancomycin, such as vancomycin-resistant Enterococcus faecium …

Persistent enterococcal bacteremia is a commonly encountered and morbid syndrome
without a strong evidence base for optimal management practices. Here we highlight reports …